Related Experiment Video
Updated: Jul 6, 2025

05:12
Induction and Micro-CT Imaging of Cerebral Cavernous Malformations in Mouse Model
Published on: September 4, 2017
11.0K
Transcriptomic signatures of individual cell types in cerebral cavernous malformation
Ying Li1,2, Romuald Girard2, Abhinav Srinath2
1Department of Neurosurgery, First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
Cell Communication and Signaling : CCS
|January 9, 2024
Summary
Cerebral cavernous malformation (CCM) involves multiple cell types. This study reveals cellular crosstalk and gene changes in CCM lesions, highlighting inflammation and angiogenesis as key pathways for potential therapeutic targets.
Area of Science:
- Neuroscience
- Genomics
- Pathology
Background:
- Cerebral cavernous malformation (CCM) is a serious hemorrhagic neurovascular disease lacking effective treatments.
- Understanding the specific roles of different cell types in CCM pathogenesis is crucial but remains unclear.
- This study employed RNA-sequencing on sorted endothelial cells (ECs), pericytes, and neuroglia from CCM lesions and controls.
Discussion:
- Common differentially expressed genes (DEGs) across cell types indicate inflammation and endothelial-to-mesenchymal transition (EndMT) are central to CCM.
- Lesional ECs contribute to aberrant angiogenesis and increased vascular permeability, while pericytes show VEGFA upregulation.
- Pericytes and neuroglia in lesions are implicated in immune responses, suggesting non-endothelial cell contributions to CCM pathology.
Key Insights:
- Dysfunctional cellular crosstalk in CCM involves inflammation, EndMT, dysregulated angiogenesis, and immune responses.
- VEGF signaling pathways are activated in lesional ECs and pericytes, promoting angiogenesis.
- CCM pathogenesis is influenced by cell-specific alterations affecting EndMT, coagulation, and hypoxia.
Outlook:
- Findings provide mechanistic hypotheses for non-endothelial cell roles in CCM lesion development.
- Identification of specific cellular pathways and gene alterations offers potential novel therapeutic targets for CCM.
- Further research into cell-specific contributions may unlock new treatment strategies for this debilitating disease.

